Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 2/2007

01-06-2007 | Original Paper

Management of extreme azotemia from urinary tract obstruction without dialysis. Clinical correlates and kinetic modeling of the recovery of renal function

Authors: Richard Wang, Antonios H. Tzamaloukas, Emmanuel I. Agaba, Karen S. Servilla, Dorothy J. VanderJagt, Laurence J. Gibel, Michael F. Hartshorne, Betty Chang

Published in: International Urology and Nephrology | Issue 2/2007

Login to get access
Metadata
Title
Management of extreme azotemia from urinary tract obstruction without dialysis. Clinical correlates and kinetic modeling of the recovery of renal function
Authors
Richard Wang
Antonios H. Tzamaloukas
Emmanuel I. Agaba
Karen S. Servilla
Dorothy J. VanderJagt
Laurence J. Gibel
Michael F. Hartshorne
Betty Chang
Publication date
01-06-2007
Publisher
Kluwer Academic Publishers
Published in
International Urology and Nephrology / Issue 2/2007
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-006-9035-3

Other articles of this Issue 2/2007

International Urology and Nephrology 2/2007 Go to the issue

Original article

Brain natriuretic peptide and P wave duration in dialysis patients

Original Paper

Penile paraffinoma: the delayed presentation

ORIGINAL PAPER

Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients

Original Paper

Brain metastases: a rare initial presentation of prostate cancer

Original Paper

Amyloidosis in a patient with autosomal dominant polycystic kidney disease and tuberculosis: a case report

Original Paper

Optical urethrotomy using topical anesthesia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits